Page last updated: 2024-08-24

temoporfin and Experimental Hepatoma

temoporfin has been researched along with Experimental Hepatoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Luo, FH; Quan, ZW; Shen, J; Shi, WB; Wang, JD; Yan, JH; Zhou, XP1
Dabkeviciene, D; Didziapetriene, J; Grazeliene, G; Juodka, B; Kirveliene, V; Kirvelis, D; Micke, I1
Molina, A; Rovers, JP; Saarnak, AE; Schuitmaker, JJ; Sterenborg, HJ; Terpstra, OT1

Other Studies

3 other study(ies) available for temoporfin and Experimental Hepatoma

ArticleYear
Optimal treatment opportunity for mTHPC-mediated photodynamic therapy of liver cancer.
    Lasers in medical science, 2013, Volume: 28, Issue:6

    Topics: Animals; Carcinoma 256, Walker; Cell Line, Tumor; Half-Life; Injections, Intravenous; Liver Neoplasms, Experimental; Male; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Rats; Rats, Wistar; Spectrometry, Fluorescence; Tissue Distribution

2013
Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
    Cancer chemotherapy and pharmacology, 2006, Volume: 57, Issue:1

    Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Administration Schedule; Female; Liver Neoplasms, Experimental; Male; Mesoporphyrins; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Photochemotherapy; Photosensitizing Agents; Xenograft Model Antitumor Assays

2006
Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
    British journal of cancer, 1999, Volume: 81, Issue:4

    Topics: Animals; Antineoplastic Agents; Fluorescence; Liver Neoplasms, Experimental; Male; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Rats

1999